These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25545182)

  • 1. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
    Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia.
    Peterson CC; Johnson CE; Ramirez LY; Huestis S; Pai AL; Demaree HA; Drotar D
    Pediatr Blood Cancer; 2008 Jul; 51(1):99-104. PubMed ID: 18322925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.
    Taga T; Shimomura Y; Horikoshi Y; Ogawa A; Itoh M; Okada M; Ueyama J; Higa T; Watanabe A; Kanegane H; Iwai A; Saiwakawa Y; Kogawa K; Yamanaka J; Tsurusawa M
    Pediatr Blood Cancer; 2011 Jul; 57(1):36-40. PubMed ID: 21557456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
    Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
    Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
    Creutzig U; Reinhardt D; Diekamp S; Dworzak M; Stary J; Zimmermann M
    Leukemia; 2005 Aug; 19(8):1355-60. PubMed ID: 15920490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
    Pediatr Blood Cancer; 2011 Dec; 57(7):1222-9. PubMed ID: 22095929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
    Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
    Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
    Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
    Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
    Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.
    Puumala SE; Ross JA; Olshan AF; Robison LL; Smith FO; Spector LG
    Cancer; 2007 Nov; 110(9):2067-74. PubMed ID: 17849462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukemias in children with Down syndrome.
    Zwaan MC; Reinhardt D; Hitzler J; Vyas P
    Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine pharmacokinetics in children with Down syndrome.
    Lönnerholm G; Frost BM; Söderhäll S; de Graaf SS
    Pediatr Blood Cancer; 2009 Jan; 52(1):123-5. PubMed ID: 18615507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.